Filing Details
- Accession Number:
- 0001415889-25-019108
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-02 17:28:57
- Reporting Period:
- 2025-07-01
- Filing Date:
- 2025-07-02
- Accepted Time:
- 2025-07-02 17:28:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1438533 | Travere Therapeutics Inc. | TVTX | Pharmaceutical Preparations (2834) | 262383102 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1902368 | Jula Inrig | C/O Travere Therapeutics, Inc. 3611 Valley Centre Drive, Suite 300 San Diego CA 92130 | Chief Medical Officer | No | No | No | No |
Transaction Summary
| Sold: | 815 shares | Avg. Price: $14.65 | Total Value: $11,939.75 |
| Number of Shares After Transactions: | 88,787 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-07-01 | 815 | $14.65 | 88,787 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This sale was made pursuant to a written plan adopted on March 15, 2024, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of additional shares to cover the tax obligation that occurred upon the vesting of performance-based restricted stock units (PSUs) that vested in February 2025.
Billionaire Hedge Funds
